Prediction: Eli Lilly and Novo Nordisk Stock Could Just be Getting Started. Here's Why

Two of the biggest names in the pharmaceutical industry right now are Eli Lilly (LLY -1.57%) and Novo Nordisk (NVO -1.55%). Each company is at the forefront of the red-hot weight-loss market due to their innovative roster of diabetes medications.Both companies develop glucagon-like peptide-1 (GLP-1) drugs, including Mounjaro, Ozempic, and Rybelsus. While these blockbuster drugs are not formally approved for chronic weight management by the Food and Drug Administration (FDA), losing weight can often be a byp ...